Tamara Miner Haygood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tamara Miner Haygood has a total of 283 co-authors. Here are the top co-authors by number of shared publications:
John E. Madewell
From the Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, 1400 Pressler St, Unit 1475, Houston, TX 77030 (B.A., W.A.M., T.M.H., R.K., K.W.M., J.E.M., B.M.M., C.M.C.); and Department of Biostatistics, Taussig Cancer Institute, Cleveland, Ohio (W.W.).
5 shared publicationsAurelio Matamoros
3 shared publications- Eva Galvan
Department of Radiation Oncology, University of Texas at San Antonio, San Antonio, TX 78229, USA
3 shared publications - William A. Murphy
University of Texas MD Anderson Cancer Center
3 shared publications Behrang Amini
Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd., Houston, Texas, USA
2 shared publications- Behrang Amini
Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center , Houston, TX
2 shared publications
Latest Publications
- 6 October 2026
- Published by Springer Nature
- p. 1207-1222
Radiation Effects in the Musculoskeletal System
- 6 October 2026
- Published by Springer Nature
- p. 1207-1222
Radiation Effects in the Musculoskeletal System
- 1 January 2023
- Published by Springer Nature
- p. 1-16
Radiation Effects in the Musculoskeletal System
- 1 April 2021
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 42 (2) , 123-133
Chondroid Tumors of Bone
- 1 April 2021
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 42 (2) , 123-133
Chondroid Tumors of Bone
- 1 April 2021
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 42 (2) , 150-163
Benign Osseous Tumors and Tumor-Like Conditions
- 1 April 2021
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 42 (2) , 150-163
Benign Osseous Tumors and Tumor-Like Conditions
- 1 March 2020
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 2 (2) , e190046
Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI
Gadolinium-based contrast agents increase diagnostic performance for detection of recurrent soft-tissue sarcoma. PurposeTo determine the diagnostic efficacy of gadolinium-based contrast agents for the detection of recurrent soft-tissue sarcoma compared with non–contrast-enhanced conventional MRI sequences.Mat...
- 1 March 2020
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 2 (2) , e190046
Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI
Gadolinium-based contrast agents increase diagnostic performance for detection of recurrent soft-tissue sarcoma. PurposeTo determine the diagnostic efficacy of gadolinium-based contrast agents for the detection of recurrent soft-tissue sarcoma compared with non–contrast-enhanced conventional MRI sequences.Mat...
- Open Access
- 3 February 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 7 (02) , 022408-11
Interpretation time for screening mammography as a function of the number of computer-aided detection marks
Mammography is the gold standard for breast cancer screening. However, it is not without shortcomings as a screening tool. Approximately 25% to 33% of visible cancers may be overlooked during a mammographic interpretation because of overlying dense breast tissue, variability in reader experience, and reader fatigue.1 To help prevent cancers from being overlooked, computer-aided detection (CAD) programs review mammograms using software designed to alert the radiologist to findings potentially associated with breast cancer, such as microcalcifications, masses, and regions of architectural distortion. CAD is notorious for creating a large number of false-positive marks.2 – 4 Its overall value in screening has been questioned, with a study in 2011 finding that in a large cohort of women undergoing screening mammography, the use of CAD decreased specificity for breast cancer detection but did not have a statistically significant improvement in detection rate or decrease in breast cancer stage, size, or nodal status.5 A later study by an overlapping group of authors of another large cohort of patients showed CAD to increase detection of ductal carcinoma in situ and to allow detection of invasive breast cancer at earlier stages.6 Other studies have also shown that CAD may provide some improvement in cancer detection at the expense of decreased specificity.7,8 Despite the mixed reviews, CAD remains in frequent use in the United States. A survey of 400 mammography sites in 2007 was followed up by surveys of the same sites in 2011 and 2016, and each time the percentage of sites using CAD for screening mammography was just over 90%, ranging from 90.2% in 2011 to 92.3% in 2016.9 CAD systems are also now being developed for use with digital tomosynthesis,10 so even though conventional mammography is becoming less frequent as a stand-alone study, information on how humans interact with CAD systems remains relevant.
- 3 February 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 7 (02) , 022408-11
Open AccessInterpretation time for screening mammography as a function of the number of computer-aided detection marks
Mammography is the gold standard for breast cancer screening. However, it is not without shortcomings as a screening tool. Approximately 25% to 33% of visible cancers may be overlooked during a mammographic interpretation because of overlying dense breast tissue, variability in reader experience, and reader fatigue.1 To help prevent cancers from being overlooked, computer-aided detection (CAD) programs review mammograms using software designed to alert the radiologist to findings potentially associated with breast cancer, such as microcalcifications, masses, and regions of architectural distortion. CAD is notorious for creating a large number of false-positive marks.2 – 4 Its overall value in screening has been questioned, with a study in 2011 finding that in a large cohort of women undergoing screening mammography, the use of CAD decreased specificity for breast cancer detection but did not have a statistically significant improvement in detection rate or decrease in breast cancer stage, size, or nodal status.5 A later study by an overlapping group of authors of another large cohort of patients showed CAD to increase detection of ductal carcinoma in situ and to allow detection of invasive breast cancer at earlier stages.6 Other studies have also shown that CAD may provide some improvement in cancer detection at the expense of decreased specificity.7,8 Despite the mixed reviews, CAD remains in frequent use in the United States. A survey of 400 mammography sites in 2007 was followed up by surveys of the same sites in 2011 and 2016, and each time the percentage of sites using CAD for screening mammography was just over 90%, ranging from 90.2% in 2011 to 92.3% in 2016.9 CAD systems are also now being developed for use with digital tomosynthesis,10 so even though conventional mammography is becoming less frequent as a stand-alone study, information on how humans interact with CAD systems remains relevant.
- 1 April 2019
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 291 (1) , 119-120
Patient Literacy and Access to Radiology Information
- 1 April 2019
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 291 (1) , 119-120
Patient Literacy and Access to Radiology Information
- Open Access
- 24 September 2018
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 5 (03) , 031412-6
Memory bias in observer-performance literature
Observer performance studies are commonly used in radiology to determine the relative fitness of imaging techniques for a particular purpose. Typically, human observers view images that differ from one another in some way to gain insight into which might be better for a particular task. Two examples, taken from the articles considered for this paper, of research questions that may be addressed using an observer-performance study follow: (1) Does chest radiography with dual-energy subtraction images improve radiologists’ ability to find small lung cancers as compared with chest radiography without dual-energy subtraction images?1 (2) Does computer-aided detection improve radiologists’ interpretations of computed tomographic (CT) colonography?2 At other times, it may not be the images that change, but rather there is a change in their presentation or in the reading environment. Depending on the design of the experiment, observers may be asked to complete a specified task under two or more different conditions or to choose which of two or more images are best suited for a task. We have called the different image types or reading conditions that are being compared “tested conditions.”
- 24 September 2018
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 5 (03) , 031412-6
Open AccessMemory bias in observer-performance literature
Observer performance studies are commonly used in radiology to determine the relative fitness of imaging techniques for a particular purpose. Typically, human observers view images that differ from one another in some way to gain insight into which might be better for a particular task. Two examples, taken from the articles considered for this paper, of research questions that may be addressed using an observer-performance study follow: (1) Does chest radiography with dual-energy subtraction images improve radiologists’ ability to find small lung cancers as compared with chest radiography without dual-energy subtraction images?1 (2) Does computer-aided detection improve radiologists’ interpretations of computed tomographic (CT) colonography?2 At other times, it may not be the images that change, but rather there is a change in their presentation or in the reading environment. Depending on the design of the experiment, observers may be asked to complete a specified task under two or more different conditions or to choose which of two or more images are best suited for a task. We have called the different image types or reading conditions that are being compared “tested conditions.”
- Open Access
- 1 March 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 208 (3) , W127
VIDEO: Preoperative CT Angiography for Anterolateral Thigh Flap Reconstructions
OBJECTIVE. This video article will review the relevant vascular anatomy of the anterolateral thigh flap, describe the CT angiography (CTA) image acquisition, and describe how to report the locations of the perforating arteries along with characteristics that may be important to the surgeon. CONCLUSION. Our method of performing and reporting CTA for patients scheduled to undergo anterolateral thigh flap reconstruction provides a reproducible method of identifying perforating vessels and communicating their location to surgeons. VIDEO. Preoperative CT Angiography for Anterolateral Thigh Flap Reconstructions.
- 1 March 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 208 (3) , W127
Open AccessVIDEO: Preoperative CT Angiography for Anterolateral Thigh Flap Reconstructions
OBJECTIVE. This video article will review the relevant vascular anatomy of the anterolateral thigh flap, describe the CT angiography (CTA) image acquisition, and describe how to report the locations of the perforating arteries along with characteristics that may be important to the surgeon. CONCLUSION. Our method of performing and reporting CTA for patients scheduled to undergo anterolateral thigh flap reconstruction provides a reproducible method of identifying perforating vessels and communicating their location to surgeons. VIDEO. Preoperative CT Angiography for Anterolateral Thigh Flap Reconstructions.
- Open Access
- 24 August 2015
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 15 (3) , e327-337
Skeletal Muscle Metastasis from Renal Cell Carcinoma: 21 cases and review of the literature
This study aimed to raise radiologists' awareness of skeletal muscle metastases (SMM) in renal cell carcinoma (RCC) cases and to clarify their imaging appearance. A retrospective analysis was undertaken of 21 patients between 44-75 years old with 72 SMM treated from January 1990 to May 2009 at the MD Anderson Cancer Center in Houston, Texas, USA. Additionally, 37 patients with 44 SMM from a literature review were analysed. Among the 21 patients, the majority of SMM were asymptomatic and detected via computed tomography (CT). Mean metastasis size was 18.3 mm and the most common site was the trunk muscles (83.3%). The interval between discovery of the primary tumour and metastasis detection ranged up to 234 months. Peripheral enhancement (47.1%) was the most common post-contrast CT pattern and non-contrasted CT lesions were often isodense. Magnetic resonance imaging (MRI) characteristics were varied. Five lesions with available T1-weighted pre-contrast images were hyperintense to the surrounding muscle. Other organ metastases were present in 20 patients. Of the 44 SMM reported in the literature, the majority were symptomatic. Average metastasis size was 53.4 mm and only 20.5% of SMM were in trunk muscles. The average interval between tumour discovery and metastasis detection was 101 months. Other organ metastases were recorded in 17 out of 29 patients. SMM should always be considered in patients with RCC, even well after primary treatment. SMM from RCC may be invisible on CT without intravenous contrast; contrast-enhanced studies are therefore recommended. SMM are often hyperintense to the surrounding muscle on T1-weighted MRI scans.
- 24 August 2015
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 15 (3) , e327-337
Open AccessSkeletal Muscle Metastasis from Renal Cell Carcinoma: 21 cases and review of the literature
This study aimed to raise radiologists' awareness of skeletal muscle metastases (SMM) in renal cell carcinoma (RCC) cases and to clarify their imaging appearance. A retrospective analysis was undertaken of 21 patients between 44-75 years old with 72 SMM treated from January 1990 to May 2009 at the MD Anderson Cancer Center in Houston, Texas, USA. Additionally, 37 patients with 44 SMM from a literature review were analysed. Among the 21 patients, the majority of SMM were asymptomatic and detected via computed tomography (CT). Mean metastasis size was 18.3 mm and the most common site was the trunk muscles (83.3%). The interval between discovery of the primary tumour and metastasis detection ranged up to 234 months. Peripheral enhancement (47.1%) was the most common post-contrast CT pattern and non-contrasted CT lesions were often isodense. Magnetic resonance imaging (MRI) characteristics were varied. Five lesions with available T1-weighted pre-contrast images were hyperintense to the surrounding muscle. Other organ metastases were present in 20 patients. Of the 44 SMM reported in the literature, the majority were symptomatic. Average metastasis size was 53.4 mm and only 20.5% of SMM were in trunk muscles. The average interval between tumour discovery and metastasis detection was 101 months. Other organ metastases were recorded in 17 out of 29 patients. SMM should always be considered in patients with RCC, even well after primary treatment. SMM from RCC may be invisible on CT without intravenous contrast; contrast-enhanced studies are therefore recommended. SMM are often hyperintense to the surrounding muscle on T1-weighted MRI scans.